Clinical Trial Update: To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of INCB086550 in patients with solid tumors; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• INCB086550 (INCB086550)

Snippet

Sponsor: Incyte Biosciences Japan GK | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED